Evidence map›Paper›PMID 37503016›Full record

ArticlebioRxiv : the preprint server for biology2023

A simulation framework for modeling the within-patient evolutionary dynamics of SARS-CoV-2.

John W Terbot, Brandon S Cooper, Jeffrey M Good, Jeffrey D Jensen

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

John W TerbotArizona State University, School of Life Sciences, Center for Evolution & Medicine, Tempe, Arizona, United States of America.
Brandon S CooperUniversity of Montana, Division of Biological Sciences, Missoula, Montana, United States of America.
Jeffrey M GoodUniversity of Montana, Division of Biological Sciences, Missoula, Montana, United States of America.
Jeffrey D JensenArizona State University, School of Life Sciences, Center for Evolution & Medicine, Tempe, Arizona, United States of America.

Funding

Surveillance genome sequencing to detect SARS-CoV-2 virus variants in MontanaP30GM140963 · NIGMS · UNIVERSITY OF MONTANA · PI BOWLER, BRUCE E · 2021 to 2025
$6.9M
The evolutionary genetics and genomics of Wolbachia effects on host physiologyR35GM124701 · NIGMS · UNIVERSITY OF MONTANA · PI Brandon S. Cooper · 2017 to 2026
$3.9M
On differentiating selective and neutral evolutionary processesR35GM139383 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI JENSEN, JEFFREY D · 2021 to 2025
$3.0M
NIGMS NIH HHS P30 GM140963NIGMS NIH HHS R35 GM124701NIGMS NIH HHS R35 GM139383
6 · The paper itself

Abstract

The global impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to considerable interest in detecting novel beneficial mutations and other genomic changes that may signal the development of variants of concern (VOCs). The ability to accurately detect these changes within individual patient samples is important in enabling early detection of VOCs. Such genomic scans for positive selection are best performed via comparison of empirical data to simulated data wherein evolutionary factors, including mutation and recombination rates, reproductive and infection dynamics, and purifying and background selection, can be carefully accounted for and parameterized. While there has been work to quantify these factors in SARS-CoV-2, they have yet to be integrated into a baseline model describing intra-host evolutionary dynamics. To construct such a baseline model, we develop a simulation framework that enables one to establish expectations for underlying levels and patterns of patient-level variation. By varying eight key parameters, we evaluated 12,096 different model-parameter combinations and compared them to existing empirical data. Of these, 592 models (~5%) were plausible based on the resulting mean expected number of segregating variants. These plausible models shared several commonalities shedding light on intra-host SARS-CoV-2 evolutionary dynamics: severe infection bottlenecks, low levels of reproductive skew, and a distribution of fitness effects skewed towards strongly deleterious mutations. We also describe important areas of model uncertainty and highlight additional sequence data that may help to further refine a baseline model. This study lays the groundwork for the improved analysis of existing and future SARS-CoV-2 within-patient data.

Indexed as

evolutionary genomicspopulation geneticsSARS-CoV-2viral evolution

Identifiers

PMID37503016
PMCPMC10370031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.